Artemis Wealth Advisors, LLC - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 1 filers reported holding KALA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Artemis Wealth Advisors, LLC ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$7,881
-78.0%
25,8740.0%0.00%
-66.7%
Q1 2022$35,853
+128.8%
25,8740.0%0.00%
+50.0%
Q4 2021$15,670
-53.8%
25,8740.0%0.00%
-60.0%
Q3 2021$33,929
-50.6%
25,8740.0%0.01%
-50.0%
Q2 2021$68,635
-21.4%
25,8740.0%0.01%
-28.6%
Q1 2021$87,282
-0.6%
25,8740.0%0.01%0.0%
Q4 2020$87,801
-9.6%
25,8740.0%0.01%
-41.7%
Q3 2020$97,125
+56.8%
25,874
+119.8%
0.02%
+14.3%
Q2 2020$61,934
+19.6%
11,7740.0%0.02%
-4.5%
Q1 2020$51,799
+138.2%
11,7740.0%0.02%
+175.0%
Q4 2019$21,745
-3.0%
11,7740.0%0.01%
-20.0%
Q3 2019$22,422
-40.4%
11,7740.0%0.01%
-47.4%
Q2 2019$37,597
-22.9%
11,7740.0%0.02%
-26.9%
Q1 2019$48,734
+69.1%
11,7740.0%0.03%
+73.3%
Q4 2018$28,816
-50.5%
11,7740.0%0.02%
-53.1%
Q3 2018$58,163
-28.1%
11,7740.0%0.03%
-45.8%
Q2 2018$80,910
+56.1%
11,774
+80.0%
0.06%
+47.5%
Q1 2018$51,8326,5420.04%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CAXTON CORP 1,430,021$9,638,0006.26%
RA Capital Management 10,874,613$73,295,0001.10%
Mesirow Financial Investment Management, Inc. 41,961$283,0000.77%
Samsara BioCapital, LLC 601,162$4,052,0000.75%
SILVERARC CAPITAL MANAGEMENT, LLC 102,198$689,0000.38%
Eventide Asset Management 3,450,000$23,253,0000.34%
Orbimed Advisors 5,465,030$36,834,0000.34%
Parkman Healthcare Partners LLC 148,433$1,000,0000.23%
Vivo Capital, LLC 786,883$5,304,0000.19%
Knights of Columbus Asset Advisors LLC 199,954$1,348,0000.13%
View complete list of KALA PHARMACEUTICALS INC shareholders